| Title |
Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin–Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study
|
|---|---|
| Published in |
Drug Safety, June 2019
|
| DOI | 10.1007/s40264-019-00846-x |
| Pubmed ID | |
| Authors |
Sandra L. Kane-Gill, Marlies Ostermann, Jing Shi, Emily L. Joyce, John A. Kellum |
X Demographics
The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 11% |
| Canada | 3 | 8% |
| Argentina | 2 | 5% |
| Italy | 1 | 3% |
| Colombia | 1 | 3% |
| Mexico | 1 | 3% |
| United Arab Emirates | 1 | 3% |
| Spain | 1 | 3% |
| Kuwait | 1 | 3% |
| Other | 3 | 8% |
| Unknown | 20 | 53% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 25 | 66% |
| Practitioners (doctors, other healthcare professionals) | 10 | 26% |
| Scientists | 2 | 5% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 32 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 22% |
| Other | 5 | 16% |
| Professor | 2 | 6% |
| Student > Bachelor | 1 | 3% |
| Student > Ph. D. Student | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 15 | 47% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 28% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 9% |
| Agricultural and Biological Sciences | 1 | 3% |
| Psychology | 1 | 3% |
| Engineering | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 17 | 53% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2022.
All research outputs
#1,452,755
of 25,885,956 outputs
Outputs from Drug Safety
#128
of 1,881 outputs
Outputs of similar age
#30,653
of 368,324 outputs
Outputs of similar age from Drug Safety
#3
of 21 outputs
Altmetric has tracked 25,885,956 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,881 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,324 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.